<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>DelveInsight Latest Press Releases</title>
<link>https://pressroom.prlog.org/DelveInsight/</link>
<description>About DelveInsight - DelveInsight is a Business Consultant and Knowledge Partner and have extensive experience across the value chain of pharmaceutical industry.</description>
<item><title>Alopecia - Market Insight, Epidemiology and Market Forecast - 2027</title>
<link>https://www.prlog.org/12712010-alopecia-market-insight-epidemiology-and-market-forecast-2027.html</link>
<description>DelveInsight's &quot;Alopecia - Market Insights, Epidemiology and Market Forecast  2027&quot; report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.</description><pubDate>Tue, 05 Jun 2018 07:32:17 GMT</pubDate></item>
<item><title>AMPA Receptor Antagonist -Pipeline Insight, 2018</title>
<link>https://www.prlog.org/12704326-ampa-receptor-antagonist-pipeline-insight-2018.html</link>
<description>&quot;AMPA Receptor Antagonist -Pipeline Insight&quot; report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across AMPA Receptor Antagonist development.</description><pubDate>Mon, 23 Apr 2018 04:53:07 GMT</pubDate></item>
<item><title>Anaplastic Thyroid Cancer - Pipeline Insight, 2017</title>
<link>https://www.prlog.org/12703601-anaplastic-thyroid-cancer-pipeline-insight-2017.html</link>
<description>&quot;Anaplastic Thyroid Cancer - Pipeline Insight, 2018&quot; report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Anaplastic Thyroid Cancer.</description><pubDate>Wed, 18 Apr 2018 09:52:56 GMT</pubDate></item>
<item><title>Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017</title>
<link>https://www.prlog.org/12703057-angina-angina-pectoris-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2017.html</link>
<description>&quot;Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018&quot; report by DelveInsight offers comprehensive insights on marketed and Phase III products for Angina (Angina Pectoris).</description><pubDate>Mon, 16 Apr 2018 07:02:34 GMT</pubDate></item>
<item><title>Acute Lung Injury - Pipeline Insight, 2018</title>
<link>https://www.prlog.org/12702269-acute-lung-injury-pipeline-insight-2018.html</link>
<description>&quot;Acute Lung Injury&quot; report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Acute Lung Injury.</description><pubDate>Wed, 11 Apr 2018 06:26:10 GMT</pubDate></item>
<item><title>Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2018</title>
<link>https://www.prlog.org/12701992-human-papillomavirus-hpv-associated-cancer-pipeline-insight-2018.html</link>
<description>&quot;Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2018&quot; report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Human papillomavirus (HPV) Associated Cancer.</description><pubDate>Tue, 10 Apr 2018 05:02:41 GMT</pubDate></item>
<item><title>Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2018</title>
<link>https://www.prlog.org/12701437-acute-renal-failure-arf-acute-kidney-injury-pipeline-insight-2018.html</link>
<description>&quot;Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2018&quot; report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Acute Renal Failure (ARF) (Acute Kidney Injury).</description><pubDate>Fri, 06 Apr 2018 05:14:51 GMT</pubDate></item>
<item><title>1,3-Beta-Glucan Synthase Inhibitor -Pipeline Insight, 2017</title>
<link>https://www.prlog.org/12699260-13-beta-glucan-synthase-inhibitor-pipeline-insight-2017.html</link>
<description>&quot;1,3-Beta-Glucan Synthase Inhibitor -Pipeline Insight, 2018&quot; report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 1,3-Beta-Glucan Synthase Inhibitor development.</description><pubDate>Mon, 26 Mar 2018 11:00:29 GMT</pubDate></item>
<item><title>Atopic Dermatitis- Market will grow with novel therapies</title>
<link>https://www.prlog.org/12669000-atopic-dermatitis-market-will-grow-with-novel-therapies.html</link>
<description>About Atopic dermatitis (AD) is a chronic inflammatory skin disease and is characterized by widespread skin lesions, which manifest as red, itchy, swollen, cracked, weeping lesions with crusting/scaling, intractable pruritus (most common and persistent...</description><pubDate>Fri, 06 Oct 2017 05:13:25 GMT</pubDate></item>
<item><title>HEPATITIS C– Highly competitive market due to large number of marketed drugs</title>
<link>https://www.prlog.org/12664439-hepatitis-highly-competitive-market-due-to-large-number-of-marketed-drugs.html</link>
<description>The Hepatitis C arena currently has around 23 marketed drugs due to the increasing number of patients globally as per the latest report of DelveInsight.</description><pubDate>Thu, 14 Sep 2017 04:33:49 GMT</pubDate></item>
<item><title>Cutaneous Squamous Cell Carcinoma – US market revenue will increase by double fold by 2025</title>
<link>https://www.prlog.org/12663069-cutaneous-squamous-cell-carcinoma-us-market-revenue-will-increase-by-double-fold-by-2025.html</link>
<description>The estimated total number of incident cases of Cutaneous Squamous Cell Carcinoma (cSCC) in the US is expected to reach 713,294 by 2025 as per the latest report of DelveInsight.</description><pubDate>Thu, 07 Sep 2017 07:32:43 GMT</pubDate></item>
<item><title>Pulmonary Arterial Hypertension (PAH) –Reaching a Global Market Size up to USD 9.9 billion by 2025</title>
<link>https://www.prlog.org/12661412-pulmonary-arterial-hypertension-pah-reaching-global-market-size-up-to-usd-9-9-billion-by-2025.html</link>
<description>Prevalent cases of PAH in the 7MM (US, Germany, Spain, Italy, France, United Kingdom and Japan) are around 70,000 in 2016, out of which females are the ones to be majorly affected with this disease, accounting for 70% of the prevalent cases.</description><pubDate>Wed, 30 Aug 2017 05:12:59 GMT</pubDate></item>
<item><title>Chimeric Antigen Receptor (CAR)T cell Immunotherapy- Competitive Landscape, Technology and Pipeline</title>
<link>https://www.prlog.org/12659634-chimeric-antigen-receptor-cart-cell-immunotherapy-competitive-landscape-technology-and-pipeline.html</link>
<description>Long shot once but now engaging giant pharmaceutical companies</description><pubDate>Mon, 21 Aug 2017 11:27:40 GMT</pubDate></item>
<item><title>Cutaneous T-Cell Lymphoma– US to have the lion's share among the 7MM's</title>
<link>https://www.prlog.org/12658257-cutaneous-cell-lymphoma-us-to-have-the-lions-share-among-the-7mms.html</link>
<description>Cutaneous T-Cell Lymphoma market size in 7MM's is estimated to increase at a CAGR of 1.6% for the forecasted period (2013-2025), as per the latest report of DelveInsight.</description><pubDate>Mon, 14 Aug 2017 11:07:34 GMT</pubDate></item>
<item><title>PD-1 and PD-L1 inhibitors- Rising with existing marketed and drugs</title>
<link>https://www.prlog.org/12657654-pd-1-and-pd-l1-inhibitors-rising-with-existing-marketed-and-drugs.html</link>
<description>Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) is the most talked about immuno-oncology target. Programmed Death 1 (PD-1) is an immune inhibitory receptor expressed on several immune cells, particularly cytotoxic T cells.</description><pubDate>Thu, 10 Aug 2017 10:44:47 GMT</pubDate></item>
<item><title>Pharmaceutical Market Research Reports!!</title>
<link>https://www.prlog.org/12646603-pharmaceutical-market-research-reports.html</link>
<description>Offering Mid-Year Discounts on Pharmaceutical Market Research Reports</description><pubDate>Thu, 15 Jun 2017 10:30:02 GMT</pubDate></item>
<item><title>Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast 2023</title>
<link>https://www.prlog.org/12644792-chemotherapy-induced-neutropenia-cin-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>Report covers ten cancer indications: Breast Cancer, Leukemia, Prostate Cancer, Lung Cancer, Cervical Cancer, Pancreatic Cancer, Colorectal Cancer, Ovarian Cancer, Hodgkin's disease and Non-Hodgkin Lymphoma</description><pubDate>Wed, 07 Jun 2017 11:33:45 GMT</pubDate></item>
<item><title>Alpha- Antitrypsin Deficiency (AATD) – Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12642236-alpha-antitrypsin-deficiency-aatd-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>This report provides an overview of the Alpha Antitrypsin Deficiency and global market size of the Alpha Antitrypsin Deficiency for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.</description><pubDate>Thu, 25 May 2017 06:59:18 GMT</pubDate></item>
<item><title>PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2017</title>
<link>https://www.prlog.org/12640793-pd-1-and-pd-l1-inhibitors-competitive-landscape-pipeline-and-market-analysis-2017.html</link>
<description>DelveInsight's report, &quot;PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, &quot;gives the comprehensive insights on the PD-1 and PD-L1 Inhibitors.</description><pubDate>Thu, 18 May 2017 11:24:14 GMT</pubDate></item>
<item><title>Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017</title>
<link>https://www.prlog.org/12639224-natural-killer-cells-therapies-competitive-landscape-technology-and-pipeline-analysis-2017.html</link>
<description>DelveInsight Report, &quot;Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, emphasizes on the currently active NK cell products in research and development.</description><pubDate>Thu, 11 May 2017 07:02:31 GMT</pubDate></item>
<item><title>Chimeric Antigen Receptor (CAR)T cell Immunotherapy- Competitive Landscape, Technology and Pipeline</title>
<link>https://www.prlog.org/12637744-chimeric-antigen-receptor-cart-cell-immunotherapy-competitive-landscape-technology-and-pipeline.html</link>
<description>DelveInsight's Report, &quot;Chimeric Antigen Receptor (CAR) T-cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2017&quot; emphasizes on the currently active CAR-T cell products in research and development.</description><pubDate>Thu, 04 May 2017 11:05:38 GMT</pubDate></item>
<item><title>Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2017</title>
<link>https://www.prlog.org/12635814-microbiome-competitive-landscape-technology-and-pipeline-analysis-2017.html</link>
<description>DelveInsight's, &quot;Microbiome-Competitive Landscape, Technology and Pipeline Analysis, 2017&quot;, the report provides comprehensive insights about microbiome based therapeutic pipeline products.</description><pubDate>Wed, 26 Apr 2017 06:09:04 GMT</pubDate></item>
<item><title>Hemophilia- Market Insights, Epidemiology and Market Forecast -2023-7MM</title>
<link>https://www.prlog.org/12633619-hemophilia-market-insights-epidemiology-and-market-forecast-2023-7mm.html</link>
<description>According to DelveInsight, the market size for Hemophilia of 7MM is estimated to be USD XX Million by 2023 at a CAGR of 6.35% for the forecast period i.e., 2013-2023</description><pubDate>Mon, 17 Apr 2017 11:48:05 GMT</pubDate></item>
<item><title>Immune Checkpoints Activators: Competitive Landscape, Technology and Pipeline Analysis 2017</title>
<link>https://www.prlog.org/12631565-immune-checkpoints-activators-competitive-landscape-technology-and-pipeline-analysis-2017.html</link>
<description>DelveInsight has recently updated Immune Checkpoints Activator Report. The report provides comprehensive insights about pipeline drugs across this Mechanism of action &amp; establish the understanding for all the pipeline drugs that fall under it.</description><pubDate>Thu, 06 Apr 2017 11:22:13 GMT</pubDate></item>
<item><title>Acne Vulgaris - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12611996-acne-vulgaris-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight's report provides the market outlook of Acne Vulgaris. The major aim of the Report is to understand the market size of indication and market potential and future share of emerging drugs to understand the possible market opportunities.</description><pubDate>Mon, 09 Jan 2017 07:29:01 GMT</pubDate></item>
<item><title>DelveInsight Announces End of the Year Discount on Reports</title>
<link>https://www.prlog.org/12603480-delveinsight-announces-end-of-the-year-discount-on-reports.html</link>
<description>DelveInsight, a leading market research and consulting company is offering discounts on its market research reports.</description><pubDate>Wed, 23 Nov 2016 06:43:55 GMT</pubDate></item>
<item><title>Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12600792-cytomegalovirus-cmv-infection-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report, Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio.</description><pubDate>Fri, 11 Nov 2016 05:24:51 GMT</pubDate></item>
<item><title>Cushing's Syndrome - Market Insights, Epidemiology and Market Forecast</title>
<link>https://www.prlog.org/12596655-cushings-syndrome-market-insights-epidemiology-and-market-forecast.html</link>
<description>DelveInsight expertise has expanded from an initial focus on Pipeline &amp; Marketed Reports to Market Forecasting and Epidemiology Reports.</description><pubDate>Tue, 25 Oct 2016 05:28:04 GMT</pubDate></item>
<item><title>Colorectal cancer (mCRC) - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12595978-colorectal-cancer-mcrc-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Colorectal cancer (mCRC)- Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Fri, 21 Oct 2016 09:59:52 GMT</pubDate></item>
<item><title>Cervical Cancer - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12593888-cervical-cancer-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report, Cervical Cancer - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio.</description><pubDate>Thu, 13 Oct 2016 05:46:33 GMT</pubDate></item>
<item><title>Gastrointestinal Stromal Tumor - Market Insights, Epidemiology and Market Forecast</title>
<link>https://www.prlog.org/12593606-gastrointestinal-stromal-tumor-market-insights-epidemiology-and-market-forecast.html</link>
<description>DelveInsight expertise has expanded from an initial focus on Pipeline &amp; Marketed Reports to Market Forecasting and Epidemiology Reports.</description><pubDate>Wed, 12 Oct 2016 08:44:07 GMT</pubDate></item>
<item><title>DelveInsight's Launch of Its New &amp; Improved Report Store</title>
<link>https://www.prlog.org/12592642-delveinsights-launch-of-its-new-improved-report-store.html</link>
<description>DelveInsight is delighted to announce the launch of its report store. Our report store is collection of 3000+ analytical reports from the pharmaceutical as well as biotechnological industry.</description><pubDate>Fri, 07 Oct 2016 07:14:31 GMT</pubDate></item>
<item><title>Renal Cell Carcinoma - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12592623-renal-cell-carcinoma-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Renal Cell Carcinoma - Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Fri, 07 Oct 2016 04:57:07 GMT</pubDate></item>
<item><title>Non Hodgkin's Lymphoma (NHL)- Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12589251-non-hodgkins-lymphoma-nhl-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Non Hodgkin's Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Fri, 23 Sep 2016 10:39:34 GMT</pubDate></item>
<item><title>Non Hodgkin's Lymphoma - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12587767-non-hodgkins-lymphoma-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Non Hodgkin's Lymphoma - Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Mon, 19 Sep 2016 04:48:01 GMT</pubDate></item>
<item><title>Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12586382-neuroendocrine-carcinoma-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Tue, 13 Sep 2016 06:55:03 GMT</pubDate></item>
<item><title>Benign Prostatic Hyperplasia- Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12584186-benign-prostatic-hyperplasia-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Benign Prostatic Hyperplasia- Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Fri, 02 Sep 2016 10:02:47 GMT</pubDate></item>
<item><title>Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12583240-fibromyalgia-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight expertise has expanded from an initial focus on Pipeline &amp; Marketed Reports to Market Forecasting and Epidemiology Reports.</description><pubDate>Tue, 30 Aug 2016 09:46:08 GMT</pubDate></item>
<item><title>Endometrial Cancer- Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12582577-endometrial-cancer-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Endometrial Cancer- Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Fri, 26 Aug 2016 10:12:24 GMT</pubDate></item>
<item><title>Ewing's Sarcoma- Market Insights, Epidemiology and Market Forecast-2023</title>
<link>https://www.prlog.org/12580977-ewings-sarcoma-market-insights-epidemiology-and-market-forecast-2023.html</link>
<description>DelveInsight, the leading market research and consulting company, has added a new report Ewing's Sarcoma- Market Insights, Epidemiology and Market Forecast-2023 to its portfolio.</description><pubDate>Fri, 19 Aug 2016 05:09:44 GMT</pubDate></item>
<item><title>T-Cell Lymphoma - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12580008-cell-lymphoma-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report T-Cell Lymphoma - Pipeline Insights, 2016 to its portfolio.</description><pubDate>Tue, 16 Aug 2016 04:31:10 GMT</pubDate></item>
<item><title>Limited Period Offer upto 40% on DelveInsight's Competitive Intelligence Reports</title>
<link>https://www.prlog.org/12578631-limited-period-offer-upto-40-on-delveinsights-competitive-intelligence-reports.html</link>
<description>DelveInsight has offered discounts with an aim to expand its services reach, by offering premium products &amp; services to its clients at discounted rates and to reward its present clients.</description><pubDate>Tue, 09 Aug 2016 10:33:15 GMT</pubDate></item>
<item><title>Gram Negative Bacterial Infections - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12577925-gram-negative-bacterial-infections-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Gram Negative Bacterial Infections - Pipeline Insights, 2016 to its portfolio.</description><pubDate>Fri, 05 Aug 2016 09:47:27 GMT</pubDate></item>
<item><title>Bromodomain and Extra-terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12576309-bromodomain-and-extra-terminal-domain-protein-bet-inhibitors-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Bromodomain and Extra-terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2016 to its portfolio.</description><pubDate>Fri, 29 Jul 2016 11:46:04 GMT</pubDate></item>
<item><title>Phosphoinositide 3-Kinase (PI3k) Inhibitors - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12574683-phosphoinositide-3-kinase-pi3k-inhibitors-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Phosphoinositide 3-Kinase (PI3k) Inhibitors – Pipeline Insights, 2016 to its portfolio.</description><pubDate>Fri, 22 Jul 2016 05:56:32 GMT</pubDate></item>
<item><title>Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016</title>
<link>https://www.prlog.org/12569192-natural-killer-cells-competitive-landscape-technology-and-pipeline-analysis-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016 to its portfolio.</description><pubDate>Wed, 29 Jun 2016 06:09:56 GMT</pubDate></item>
<item><title>Diabetic Nephropathy - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12567132-diabetic-nephropathy-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Diabetic Nephropathy- Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight.</description><pubDate>Tue, 21 Jun 2016 12:08:13 GMT</pubDate></item>
<item><title>Ovarian Cancer - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12566303-ovarian-cancer-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Ovarian Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight.</description><pubDate>Fri, 17 Jun 2016 05:02:04 GMT</pubDate></item>
<item><title>Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016</title>
<link>https://www.prlog.org/12565651-estrogen-receptor-positive-er-breast-cancer-pipeline-insights-2016.html</link>
<description>DelveInsight, the leading market research and consulting company has added new report Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016 to its portfolio.</description><pubDate>Wed, 15 Jun 2016 05:38:07 GMT</pubDate></item>
<item><title>Acne Vulgaris - Market Insights, Epidemiology and Market Forecast-2022</title>
<link>https://www.prlog.org/12564313-acne-vulgaris-market-insights-epidemiology-and-market-forecast-2022.html</link>
<description>DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information.</description><pubDate>Thu, 09 Jun 2016 11:02:29 GMT</pubDate></item>
</channel>
</rss>